Last reviewed · How we verify
Neoadjuvant tamoxifen + goserelin (premenopausal women) (neoadjuvant-tamoxifen-goserelin-premenopausal-women)
Neoadjuvant tamoxifen + goserelin (premenopausal women) (generic name: neoadjuvant-tamoxifen-goserelin-premenopausal-women) is a drug developed by Pfizer Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | neoadjuvant-tamoxifen-goserelin-premenopausal-women |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer (PHASE2)
- PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial (PHASE2)
- (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer (PHASE2)
- Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Neoadjuvant tamoxifen + goserelin (premenopausal women) CI brief — competitive landscape report
- Neoadjuvant tamoxifen + goserelin (premenopausal women) updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Neoadjuvant tamoxifen + goserelin (premenopausal women)
What is Neoadjuvant tamoxifen + goserelin (premenopausal women)?
Neoadjuvant tamoxifen + goserelin (premenopausal women) (neoadjuvant-tamoxifen-goserelin-premenopausal-women) is a pharmaceutical drug developed by Pfizer Inc..
Who makes Neoadjuvant tamoxifen + goserelin (premenopausal women)?
Neoadjuvant tamoxifen + goserelin (premenopausal women) is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Neoadjuvant tamoxifen + goserelin (premenopausal women)?
neoadjuvant-tamoxifen-goserelin-premenopausal-women is the generic (nonproprietary) name of Neoadjuvant tamoxifen + goserelin (premenopausal women).
What development phase is Neoadjuvant tamoxifen + goserelin (premenopausal women) in?
Neoadjuvant tamoxifen + goserelin (premenopausal women) is in Phase 2.